Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne

Completed · Not applicable

Conditions studied: Facial Acne

In brief

This study will evaluate the effectiveness of Ultherapy for the treatment of facial acne.

Key facts

Study ID

NCT01591304

Run by

Ulthera, Inc

People needed

24

Starts

2011-08-01

Expected to finish

2014-07-01

Last updated by the study team

2017-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, aged 18 years and older.
• Subject in good health.
• Presence of clinically-evident facial acne of moderate to severe severity with at least 20 inflammatory lesions and 20-100 noninflammatory lesions.

You may not qualify if…

• Presence of >2 nodular lesions in the areas to be treated.
• Presence of any cysts in the areas to be treated.
• Presence of an active systemic or local skin disease that may affect wound healing.
• Use of alcohol-based topical solutions or "exfoliating" agents within 1 week prior to study participation.
• History of frequent herpes simplex infections of the face or with clinical evidence of active herpes simplex infections.
• History of keloid scar formation.
• Significant scarring in areas to be treated.
• Significant open facial wounds or lesions.
• Presence of a metal stent or implant in the facial area to be treated.

Where it is running

• Multispecialty Aesthetic Clinical Research Organization — Woodland Hills, California, United States
• Dermatology, Laser & Vein Specialists of the Carolinas — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.